Tumor immunotherapy: inching toward the finish line
- PMID: 11827989
- PMCID: PMC150867
- DOI: 10.1172/JCI15042
Tumor immunotherapy: inching toward the finish line
Comment on
-
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors.J Clin Invest. 2002 Feb;109(3):409-17. doi: 10.1172/JCI14364. J Clin Invest. 2002. PMID: 11828001 Free PMC article.
References
-
- Bailar JC, III, Gornik HL. Cancer undefeated. N Engl J Med. 1997;336:1569–1574. - PubMed
-
- Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature. 2001;411:380–384. - PubMed
-
- Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245–252. - PubMed
-
- Balter M. Gene therapy on trial. Science. 2000;288:951–957. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
